All Stories

Galapagos gets cold feet over plans to split up company

Only five months after Galapagos announced it would split in two, the cell-therapy-focused biotech is already having second thoughts.

May 13, 2025 - 12:08
 0
Galapagos gets cold feet over plans to split up company
Only five months after Galapagos announced it would split in two, the cell-therapy-focused biotech is already having second thoughts.
Read More

Tags:

Previous Article

Twelve Years After Hitting the Market, Men’s Grooming Brand Harry’s Is Launching...

Next Article

J&J, Eli Lilly join $85M financing for newly unveiled gene editing biotech Stylus

Related Posts

Anti-aging biotech NewLimit raises $130M to push liver reprogramming med into clinic

Anti-aging biotech NewLimit raises $130M to push liver ...

May 8, 2025  0

Lexeo laid off 15% of staff in April to focus on lead cardiac gene therapies

Lexeo laid off 15% of staff in April to focus on lead c...

May 12, 2025  0

Fierce Biotech Layoff Tracker 2025: 10x Genomics cuts 8% of global workforce; NGM sheds 75% of staff

Fierce Biotech Layoff Tracker 2025: 10x Genomics cuts 8...

May 12, 2025  0